Difference between revisions of "Malignant mesothelioma"

Jump to navigation Jump to search
Line 59: Line 59:
Features:<ref name=Ref_WMSP156>{{Ref WMSP|156}}</ref>
Features:<ref name=Ref_WMSP156>{{Ref WMSP|156}}</ref>
*Infiltrative atypical cells - '''key feature'''.
*Infiltrative atypical cells - '''key feature'''.
**Infiltration into fat - ''diagnostic''.
**+/-Epithelioid cells - may be cytologically bland, i.e. benign appearing.
**+/-Epithelioid cells - may be cytologically bland, i.e. benign appearing.
***Variable architecture: sheets, microglandular, tubulopapillary.
***Variable architecture: sheets, microglandular, tubulopapillary.
Line 67: Line 68:
** Thin (asbestos) fiber in the core.  
** Thin (asbestos) fiber in the core.  


Note:
Notes:
*''Asbestos body'' is not strictly speaking a synonym for ''ferruginous body''.
*''Asbestos body'' is not strictly speaking a synonym for ''ferruginous body''.
*Don't diagnose ''mesothelioma in situ''.{{fact}}


DDx:<ref name=pmid15559051>{{Cite journal  | last1 = Corson | first1 = JM. | title = Pathology of mesothelioma. | journal = Thorac Surg Clin | volume = 14 | issue = 4 | pages = 447-60 | month = Nov | year = 2004 | doi = 10.1016/j.thorsurg.2004.06.007 | PMID = 15559051 }}
DDx:<ref name=pmid15559051>{{Cite journal  | last1 = Corson | first1 = JM. | title = Pathology of mesothelioma. | journal = Thorac Surg Clin | volume = 14 | issue = 4 | pages = 447-60 | month = Nov | year = 2004 | doi = 10.1016/j.thorsurg.2004.06.007 | PMID = 15559051 }}
</ref>
</ref>
*[[Fibrosing pleuritis]].
*[[Fibrosing pleuritis]] - should ''not'' have nodules, more cellular on the aspect adjacent to the effusion.
*Reactive mesothelial cells - may be atypical.
*Mesothelial hyperplasia.
*Mesothelial hyperplasia.
*[[Adenocarcinoma]] - esp. [[lung adenocarcinoma]].
*[[Adenocarcinoma]] - esp. [[lung adenocarcinoma]].
48,453

edits

Navigation menu